Trials
Search / Trial NCT05649319

ERAS on Postoperative Recovery After Laparoscopic Distal Gastrectomy

Launched by SEOUL NATIONAL UNIVERSITY HOSPITAL · Dec 5, 2022

Apply for Trial

Trial Information

Current as of February 05, 2025

Completed

Keywords

Enhanced Recovery After Surgery Stomach Neoplasms Gastrectomy Pain, Postoperative

ClinConnect Summary

Adult patients undergoing elective laparoscopic distal gastrectomy are randomly allocated to receive the ERAS protocol (n=49) or conventional protocol (n=49). The conventional groups receive our current perioperative management. The ERAS groups receive our new ERAS protocol including preoperative carbohydrate loading, shortening of perioperative fasting time, and multimodal opioid-sparing analgesia. The primary outcome measure was the postoperative quality of recovery evaluated using the Korean version of Quality of recovery-15 at 24, 48, and 72 hours postoperatively. The secondary outcome ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • Patients scheduled to undergo elective laparoscopic distal gastrectomy
  • • American Society of Anesthesiologists (ASA)physical classification I-II
  • • ECOG Performance Status Scale 0 or 1
  • • Willingness and ability to sign an informed consent document
  • Exclusion Criteria:
  • • Patients with chronic pain
  • • Gastrectomy with combined resection of other organs
  • • Patients with history of upper abdominal surgery
  • • Allergies to anesthetic or analgesic medications (fentanyl, ropivacaine, acetaminophen, NSAIDs)
  • • Medical or psychological disease that can affect the treatment response

Trial Officials

Do Joong Park, MD, PhD

Study Director

Seoul National University Hospital

About Seoul National University Hospital

Seoul National University Hospital (SNUH) is a leading medical institution in South Korea, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent clinical trial sponsor, SNUH integrates cutting-edge scientific inquiry with patient-centered care, facilitating the development of novel therapies and treatment protocols. The hospital boasts a diverse range of specialized departments and a robust infrastructure for conducting clinical studies, ensuring rigorous adherence to ethical standards and regulatory compliance. By fostering collaboration among multidisciplinary teams, SNUH aims to contribute significantly to global medical advancements and improve patient outcomes.

Locations

Seoul, , Korea, Republic Of

Seoul, , Korea, Republic Of

Seoul, , Korea, Republic Of

Seoul, Seoul Teugbyeolsi, Korea, Republic Of

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials